| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Syndax Pharmaceuticals Inc (NASDAQ: SNDX)
SNDX Technical Analysis
4
| As on 9th Jun 2023 SNDX STOCK Price closed @ 21.16 and we RECOMMEND Buy for LONG-TERM with Stoploss of 19.51 & Strong Buy for SHORT-TERM with Stoploss of 17.57 we also expect STOCK to react on Following IMPORTANT LEVELS. |
SNDXSTOCK Price
| Open | 21.34 | Change | Price | % |
| High | 21.60 | 1 Day | -0.16 | -0.75 |
| Low | 20.94 | 1 Week | 1.25 | 6.28 |
| Close | 21.16 | 1 Month | 0.35 | 1.68 |
| Volume | 561700 | 1 Year | 0.02 | 0.09 |
| 52 Week High 28.98 | 52 Week Low 13.64 | ||||
NASDAQ USA Most Active Stocks
| TSLA | 244.40 | 4.06% |
| TTOO | 0.07 | -12.50% |
| SOFI | 8.18 | 0.74% |
| FFIE | 0.33 | 6.45% |
| PONO | 1.72 | 2.38% |
| AMD | 124.92 | 3.20% |
| IDEX | 0.06 | 0.00% |
| NKLA | 0.70 | 14.75% |
| AMZN | 123.43 | -0.66% |
| AAPL | 180.96 | 0.22% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
| SNDX Daily Charts |
SNDX Intraday Charts |
Whats New @ Bazaartrend |
SNDX Free Analysis |
|
|
SNDX Important Levels Intraday
| RESISTANCE | 22.43 |
| RESISTANCE | 22.02 |
| RESISTANCE | 21.77 |
| RESISTANCE | 21.52 |
| SUPPORT | 20.80 |
| SUPPORT | 20.55 |
| SUPPORT | 20.30 |
| SUPPORT | 19.89 |
SNDX Forecast April 2024
| 4th UP Forecast | 31.93 |
| 3rd UP Forecast | 28.48 |
| 2nd UP Forecast | 26.34 |
| 1st UP Forecast | 24.21 |
| 1st DOWN Forecast | 18.11 |
| 2nd DOWN Forecast | 15.98 |
| 3rd DOWN Forecast | 13.84 |
| 4th DOWN Forecast | 10.39 |
SNDX Weekly Forecast
| 4th UP Forecast | 24.63 |
| 3rd UP Forecast | 23.52 |
| 2nd UP Forecast | 22.83 |
| 1st UP Forecast | 22.14 |
| 1st DOWN Forecast | 20.18 |
| 2nd DOWN Forecast | 19.49 |
| 3rd DOWN Forecast | 18.80 |
| 4th DOWN Forecast | 17.69 |
SNDX Forecast2024
| 4th UP Forecast | 53.13 |
| 3rd UP Forecast | 42.88 |
| 2nd UP Forecast | 36.54 |
| 1st UP Forecast | 30.2 |
| 1st DOWN Forecast | 12.12 |
| 2nd DOWN Forecast | 5.78 |
| 3rd DOWN Forecast | -0.56 |
| 4th DOWN Forecast | -10.81 |
Syndax Pharmaceuticals Inc ( NASDAQ USA Symbol : SNDX )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
SNDX Business Profile
Syndax Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancer. Its lead product candidates are SNDX-5613, which is in phase 1/2 clinical trial targeting the binding interaction of Menin with the mixed lineage leukemia 1 protein for the treatment of MLL-rearranged (MLLr) and nucleophosmin 1 mutant acute myeloid leukemia (NPM1c AML); and SNDX-6352 or axatilimab, a monoclonal antibody that blocks the colony stimulating factor 1, or CSF-1 receptor for the treatment of patients with chronic graft versus host disease (cGVHD). The company is also developing Entinostat. It also has collaborative research and development agreement with National Cancer Institute; a clinical trial agreement with Eastern Cooperative Oncology Group; and a license agreement with Kyowa Hakko Kirin Co., Ltd. The company was incorporated in 2005 and is headquartered in Waltham, Massachusetts. Address: 35 Gatehouse Drive, Waltham, MA, United States, 02451
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service